Member Exclusive News

Novel drug candidate could treat visceral leishmaniasis

Collaborative research between the University of Dundee, GSK and Wellcome has uncovered a new preclinical drug candidate that could treat one of the world’s major neglected diseases.

Go to the profile of Jasmine Harris
Jul 27, 2018
2
0

Please sign in or register for FREE

Register to RxNet

RxNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.

Register

No comments yet.